Stem Cell Therapy for Alzheimer's Disease
Support cognitive function and neuroprotection with regenerative MSC therapy.
Understanding Alzheimer's
Alzheimer's disease is a progressive neurodegenerative condition that affects memory, thinking, and behavior. It is the most common cause of dementia, accounting for 60-80% of dementia cases worldwide. The disease is characterized by the accumulation of amyloid-beta plaques and tau tangles in the brain, leading to neuronal death and brain atrophy.
As the disease progresses, it impairs the ability to carry out daily activities, recognize loved ones, and eventually affects basic functions like swallowing and walking. Current pharmaceutical treatments can temporarily slow symptom progression but cannot halt or reverse the underlying neurodegeneration.
Regenerative medicine represents an emerging field of research for Alzheimer's, focusing on the potential of MSCs to support neuroprotection, reduce neuroinflammation, and promote the survival of existing neurons. While no cure exists, these approaches aim to support brain health and slow disease progression.
Common Symptoms
- Progressive memory loss, especially recent memories
- Difficulty with problem-solving and planning
- Confusion about time, place, or identity
- Challenges with language and word-finding
- Poor judgment and decision-making
- Withdrawal from social activities
- Changes in mood and personality
How MSC Therapy May Help
MSCs may support Alzheimer's patients through multiple mechanisms. Their ability to release neurotrophic factors such as BDNF, NGF, and VEGF may help protect existing neurons from further damage and support the survival of brain cells in regions affected by the disease.
MSCs demonstrate strong anti-inflammatory properties that may help reduce neuroinflammation, a key driver of Alzheimer's progression. Chronic brain inflammation contributes to neuronal death and accelerates cognitive decline. By modulating the brain's immune cells (microglia), MSCs may help create a more supportive environment for neural health.
Preclinical studies suggest that MSCs may also help reduce the accumulation of amyloid-beta plaques through the activation of microglial phagocytosis, the brain's natural cleanup mechanism. Additionally, MSC-derived exosomes have shown the ability to cross the blood-brain barrier and deliver neuroprotective cargo directly to brain tissue.
Our Treatment Approach
Cognitive Assessment
Thorough neurological and cognitive evaluation including memory testing, brain imaging review, and functional assessment to establish a treatment baseline.
IV MSC Infusion
Systemic intravenous delivery of Wharton's Jelly MSCs to provide neuroprotective factors and reduce systemic inflammation affecting brain health.
Exosome Therapy
MSC-derived exosomes administered to deliver bioactive molecules across the blood-brain barrier for direct neural support and anti-inflammatory action.
Holistic Support
Comprehensive lifestyle and nutritional guidance including brain-healthy nutrition, cognitive exercises, and caregiver support resources.
Expected Benefits
- May support neuroprotection of existing brain cells
- May help reduce neuroinflammation
- Supports cognitive function maintenance
- May promote neural repair mechanisms
- Supports overall brain health and vitality
- May complement existing treatment strategies
Frequently Asked Questions About Alzheimer's
Current research does not support claims of reversing Alzheimer's disease. However, MSC therapy may help support neuroprotection, reduce neuroinflammation, and potentially slow disease progression. The goal is to maintain cognitive function and quality of life for as long as possible.
Early intervention generally offers the greatest potential for benefit, as there are more neurons to protect and support. However, patients at various stages may experience improvements. The medical team evaluates each patient individually to set realistic expectations.
Treatment primarily involves intravenous infusion of MSCs, which is non-invasive and well-tolerated. Exosome therapy may also be included to enhance delivery of neuroprotective factors to the brain. The protocol is adapted to each patient's needs and tolerance.
Reported outcomes vary but may include stabilization of cognitive function, improved alertness and engagement, better sleep patterns, and enhanced quality of life. Family members often notice improvements in daily functioning and communication. Individual results depend on disease stage and overall health.
Ready to Explore Your Treatment Options?
Schedule a personalized consultation to discuss how MSC therapy may support your health journey.